Is the regulation of SIRT1 by miRNA-34a the key to mesenchymal stem cell survival?

Mesenchymal stem cells (MSCs) are currently being used clinically to treat cardiovascular diseases, including ischemic heart disease, heart failure, and peripheral vascular disease (1,2).